2025
When the farm turns fatal: a rare infection causing heart block
Abid S, Stolear A, Dulgher M, Sethi S, Zarich S. When the farm turns fatal: a rare infection causing heart block. Oxford Medical Case Reports 2025, 2025: omaf010. PMID: 40162143, PMCID: PMC11952902, DOI: 10.1093/omcr/omaf010.Peer-Reviewed Original ResearchHeart blockCardiac complicationsDual-chamber pacemaker implantationRegimen of doxycyclineBlood culturesAntibiotic therapyPacemaker placementRare infectionConduction abnormalitiesNonspecific symptomsPacemaker implantationDifferential diagnosisEarly recognitionUnique caseBrucellosis-endemic areasEndemic regionsHeart rhythmComplicationsHeartPatientsZoonotic infectionInfectionBacteremiaHypotensionRifampinThe Natural History of Congenital Hepatic Hemangiomas
Ostertag-Hill C, Fevurly R, Kulungowski A, Christison-Lagay E, McGuire A, Rialon K, Duggan E, Murillo R, Zurakowski D, Staffa S, Alomari A, Kozakewich H, Al-Ibraheemi A, Fishman S, Dickie B. The Natural History of Congenital Hepatic Hemangiomas. The Journal Of Pediatrics 2025, 281: 114523. PMID: 40023218, DOI: 10.1016/j.jpeds.2025.114523.Peer-Reviewed Original ResearchCongenital hepatic hemangiomasCongenital HHHepatic hemangiomaMedical therapyRetrospective review of patientsNatural historyReview of patientsKaplan-Meier curvesMonths of ageCongenital hemangiomaRetrospective reviewClinical presentationRespiratory failureClinical behaviorHeart failureHH volumeHistological findingsEarly recognitionResidual volumeGeneralized Estimating EquationsIncorrect diagnosisHemangiomaPatientsNo differenceRate of involution
2024
Corrigendum to “Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease” [Autoimmunity Reviews - Volume 23, Issue 6, June 2024, 103582]
Guiot J, Miedema J, Cordeiro A, De Vries-Bouwstra J, Dimitroulas T, Søndergaard K, Tzouvelekis A, Smith V. Corrigendum to “Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease” [Autoimmunity Reviews - Volume 23, Issue 6, June 2024, 103582]. Autoimmunity Reviews 2024, 23: 103641. PMID: 39369613, DOI: 10.1016/j.autrev.2024.103641.Peer-Reviewed Original ResearchPrimary left atrial rhabdomyosarcoma in a 42-year-old patient: an unusual cardiac tumor presentation
Akman Z, Belpinar M, Zanbak Mutlu Ö, Mutlu D. Primary left atrial rhabdomyosarcoma in a 42-year-old patient: an unusual cardiac tumor presentation. Journal Of Cardiology & Cardiovascular Surgery 2024, 2: 31-33. DOI: 10.51271/jccvs-0031.Peer-Reviewed Original ResearchPrimary cardiac malignanciesComprehensive diagnostic workupCardiac malignanciesTumor presentationSurgical treatmentDiagnostic workupPulmonary edemaCase reportClinical detailsEarly recognitionAggressive naturePrompt interventionRhabdomyosarcomaWeight lossMalignancyEdemaWorkupAtriaPatientsDiagnosisSymptoms
2023
Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease
Sandokji I, Xu Y, Denburg M, Furth S, Abraham A, Greenberg J. Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease. Nephron 2023, 148: 1-10. PMID: 37232009, PMCID: PMC10840447, DOI: 10.1159/000530918.Peer-Reviewed Original ResearchChronic kidney diseaseCKD progressionKidney diseaseNovel biomarkersProgression of CKDLong-term adverse outcomesPediatric chronic kidney diseaseKidney function declineGlomerular filtration rateRisk of deathScreening studyCKD pathophysiologyFunction declineKidney biomarkersAdverse outcomesProgression riskFiltration rateClinical managementEarly recognitionClinical trialsPrognostic markerEarly diagnosisHigh riskClinical practicePromising biomarkerThe current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder
Castagna P, Farahdel E, Potenza M, Crowley M. The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder. Expert Opinion On Pharmacotherapy 2023, 24: 835-847. PMID: 37074259, PMCID: PMC10197951, DOI: 10.1080/14656566.2023.2199921.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSelective serotonin reuptake inhibitorsSelective norepinephrine reuptake inhibitorGeneralized anxiety disorderAnxiety disordersReuptake inhibitorsPediatric generalized anxiety disorderBetter long-term outcomesSecond-line treatmentNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitorsFirst-line interventionLong-term outcomesCombination of psychotherapyPrevalent psychiatric disordersEvidence-based statePediatric anxiety disordersArt pharmacotherapyModerate effect sizeFunctional outcomeEarly recognitionMood disordersElevated riskPsychiatric disordersBetter outcomesElectronic databasesDiabetic Kidney Disease An Update
Gupta S, Dominguez M, Golestaneh L. Diabetic Kidney Disease An Update. 2023, 107: 689-705. PMID: 37258007, DOI: 10.1016/j.mcna.2023.03.004.Peer-Reviewed Original ResearchConceptsDiabetic kidney diseaseKidney diseaseManagement of diabetic kidney diseaseEnd-stage kidney diseaseChronic kidney diseaseGlobal health burdenPrimary care settingMechanisms of diabetic kidney diseaseAggressive managementPublic health challengePathophysiological mechanismsDiabetic nephropathyEarly recognitionClinical trialsCare settingsTherapeutic interventionsHealth burdenHealth challengesDiseaseDiagnostic termsNephropathyUnited States
2022
Early Adherence to Prescribed Brace Wear for Adolescent Idiopathic Scoliosis Is Associated With Future Brace Wear
Linden G, Emans J, Karlin L, O’Neill N, Williams K, Hresko M. Early Adherence to Prescribed Brace Wear for Adolescent Idiopathic Scoliosis Is Associated With Future Brace Wear. Spine 2022, 48: 8-14. PMID: 35917288, DOI: 10.1097/brs.0000000000004446.Peer-Reviewed Original ResearchConceptsAdolescent idiopathic scoliosisBrace wearFuture adherenceAdherent patientsIdiopathic scoliosisScoliosis Research Society (SRS) criteriaInitial adherenceRisser stage 4Consecutive AIS patientsRetrospective cohort studyCurve improvementNonadherent patientsCohort studySingle centerNonadherent groupPrescription lengthAIS patientsEarly recognitionSociety criteriaBACKGROUND DATACobb angleImproved adherenceThoracic curvePatientsSupportive interventionsTwo Cases Surviving Macro Fat Emboli Complications Following Gluteal Fat Grafting
Wolfe E, Weber L, Wo L, Samaha M, Mathew P, Garcia O, Singh D. Two Cases Surviving Macro Fat Emboli Complications Following Gluteal Fat Grafting. Aesthetic Surgery Journal 2022, 42: 902-906. PMID: 35311886, DOI: 10.1093/asj/sjac063.Peer-Reviewed Original ResearchConceptsGluteal fat graftingFat graftingFat transferLack of published outcomesLow level of evidenceFatal pulmonary embolismAutologous fat transferLevel of evidenceTertiary care settingCase of survivalComplication ratePulmonary embolismLethal complicationCardiopulmonary compromiseGluteal augmentationIntravenous passageEarly recognitionGluteal contouringInjected fatIncreased patient demandComplicationsEmboliPublished studiesLethal eventGraftThe Multiple Sclerosis Prodrome: Evidence to Action
Tremlett H, Munger KL, Makhani N. The Multiple Sclerosis Prodrome: Evidence to Action. Frontiers In Neurology 2022, 12: 761408. PMID: 35173664, PMCID: PMC8841819, DOI: 10.3389/fneur.2021.761408.Peer-Reviewed Original ResearchMultiple sclerosisProdromal phaseEarly recognitionImproved disease courseProdromal multiple sclerosisImmune-mediated diseasesMultiple sclerosis prodromeEarly disease managementDisease courseProdromal featuresDefinitive diagnosisClassical diseaseGeneral populationMS prodromeDisease preventionProdromeMajor long-term implicationsDisease managementPrognosisDiseaseLong-term implicationsPreventionSclerosisEvidenceSymptoms
2021
Pharyngo-esophago-gastric dysmotility in intubated patients: A comprehensive review
Kumbasar U, Bonde P. Pharyngo-esophago-gastric dysmotility in intubated patients: A comprehensive review. Tuberkuloz Ve Toraks 2021, 69: 392-398. PMID: 34581161, DOI: 10.5578/tt.20219712.Peer-Reviewed Original ResearchConceptsPulmonary complicationsGastric dysmotilityMajor surgeryGastric dysmotility disordersMajor pulmonary complicationsProlonged hospital stayPreventive measuresAvailable diagnostic toolsUnderlying mechanismBasic preventive measuresDysmotility disordersHospital staySwallowing dysfunctionIntubated patientsAssociated complicationsEndotracheal intubationMechanical ventilationEarly recognitionRisk factorsIndividual patientsMEDLINE databaseComplicationsLiterature searchRelevant studiesDysmotilityPharmacological Adjuncts to Palliation in the Trauma Patient: Optimal Symptom Management
Ammar M, Ammar A, Cheung C, Akhtar S. Pharmacological Adjuncts to Palliation in the Trauma Patient: Optimal Symptom Management. Current Trauma Reports 2021, 7: 73-82. DOI: 10.1007/s40719-021-00215-z.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsTrauma patientsSymptom managementQuality of lifePalliative careOptimal symptom managementPatients' symptom managementAdequate palliative careMultidisciplinary team approachHealth care costsSummaryPalliative careEnd of lifePharmacological managementCommon symptomsEarly recognitionEffective pharmacotherapyVulnerable patientsPharmacological adjunctsLife carePatientsReviewThe purposeCare costsPatient careTeam approachCareSymptomsAssociation of Vaping and Respiratory Health among Youth in the Population Assessment of Tobacco and Health (PATH) Study Wave 3
Cherian C, Buta E, Simon P, Gueorguieva R, Krishnan-Sarin S. Association of Vaping and Respiratory Health among Youth in the Population Assessment of Tobacco and Health (PATH) Study Wave 3. International Journal Of Environmental Research And Public Health 2021, 18: 8208. PMID: 34360499, PMCID: PMC8346152, DOI: 10.3390/ijerph18158208.Peer-Reviewed Original ResearchConceptsDry coughRespiratory manifestationsHigher oddsExercise-induced wheezingPulmonary clinical manifestationsSerious pulmonary complicationsNicotine product useLogistic regression modelsPulmonary complicationsAsthma diagnosisInhaler useWave 3Clinical manifestationsRespiratory healthEarly recognitionHealth SurveyTobacco useClinical effortsLifetime numberPrevention effortsPast yearPopulation AssessmentWheezingProduct useCoughThe multiple sclerosis prodrome
Makhani N, Tremlett H. The multiple sclerosis prodrome. Nature Reviews Neurology 2021, 17: 515-521. PMID: 34155379, PMCID: PMC8324569, DOI: 10.1038/s41582-021-00519-3.Peer-Reviewed Original ResearchConceptsMultiple sclerosisMS prodromeProdromal phaseCause of MSLong-term disabilityMultiple sclerosis prodromePutative risk factorsProfound clinical implicationsRelapse rateClinical featuresEarly recognitionInflammatory diseasesRisk factorsEarly initiationProdromePotential biomarkersClinical implicationsTypical symptomsDiseaseSymptomsFuture initiativesSclerosisMajor knowledge gapsBiomarkersPossible durationPatient‐detectable responsive neurostimulation as a seizure warning system
Quraishi IH, Hirsch LJ. Patient‐detectable responsive neurostimulation as a seizure warning system. Epilepsia 2021, 62: e110-e116. PMID: 34018182, PMCID: PMC8629031, DOI: 10.1111/epi.16933.Peer-Reviewed Original ResearchConceptsResponsive neurostimulation systemFocal impaired awareness seizuresProportion of patientsQuality of lifeSeizure warningTolerable symptomsClinical seizuresLatter therapySelect patientsAwareness seizuresEpileptiform activityEarly recognitionResponsive neurostimulationEpileptiform patternsCognitive impairmentPatientsNeurostimulation systemSymptomsSeizuresTherapyTreatment of clustersStimulationSeizure warning systemSeizure recognitionEpilepsyPharmacotherapy for Nonconvulsive Seizures and Nonconvulsive Status Epilepticus
Bravo P, Vaddiparti A, Hirsch LJ. Pharmacotherapy for Nonconvulsive Seizures and Nonconvulsive Status Epilepticus. Drugs 2021, 81: 749-770. PMID: 33830480, DOI: 10.1007/s40265-021-01502-4.Peer-Reviewed Original ResearchConceptsNonconvulsive status epilepticusAntiseizure medicationsNonconvulsive seizuresStatus epilepticusIll patientsRefractory nonconvulsive status epilepticusFurther neurological injuryMultiple antiseizure medicationsAdverse neurological outcomesContinuous electroencephalogram monitoringLong-term outcomesHemodynamic labilityRecent neurosurgerySeizure burdenNeurological outcomePharmacological managementBrain infectionGlobal hypoxiaNeurological injuryEarly recognitionMost seizuresUnderlying conditionClinical trialsElectroencephalogram monitoringHepatic function
2020
Oral lymphangiectasia and gastrointestinal Crohn disease
Lenskaya V, Panji P, de Moll E, Christian K, Phelps R. Oral lymphangiectasia and gastrointestinal Crohn disease. Journal Of Cutaneous Pathology 2020, 47: 1080-1084. PMID: 32761835, DOI: 10.1111/cup.13834.Peer-Reviewed Original ResearchConceptsMelkersson-Rosenthal syndromeCrohn's diseaseCheilitis granulomatosaTreated with systemic steroidsNon-caseating granulomasClinical contextIntralymphatic granulomasLip edemaSystemic steroidsLip swellingOral symptomsPathological evaluationDiagnosing GCHistopathological findingsGastrointestinal symptomsLymphatic obstructionPathological findingsEarly recognitionEarly diagnosisWork-upSymptoms of CDLymphangiectasiaGranulomaYoung womenGastrointestinal diseasesRecognizing Axial Spondyloarthritis: A Guide for Primary Care
Magrey MN, Danve AS, Ermann J, Walsh JA. Recognizing Axial Spondyloarthritis: A Guide for Primary Care. Mayo Clinic Proceedings 2020, 95: 2499-2508. PMID: 32736944, DOI: 10.1016/j.mayocp.2020.02.007.Peer-Reviewed Original ResearchConceptsInflammatory back painBack painAxial spondyloarthritisHuman leukocyte antigen-B27 positivityChronic low back painNonsteroidal anti-inflammatory drugsExtra-articular manifestationsAge 45 yearsChronic back painLow back painAnti-inflammatory drugsEnglish-language articlesButtock painMorning stiffnessPeripheral arthritisSymptom onsetB27 positivityInsidious onsetAxial SpASpA featuresPrimary careEarly recognitionActive axSpAEffective therapyFamily historyCutaneous immune-related adverse events to checkpoint inhibitors
Malviya N, Tattersall IW, Leventhal J, Alloo A. Cutaneous immune-related adverse events to checkpoint inhibitors. Clinics In Dermatology 2020, 38: 660-678. PMID: 33341200, DOI: 10.1016/j.clindermatol.2020.06.011.Peer-Reviewed Original ResearchConceptsAdverse reactionsCheckpoint inhibitorsImmune-related adverse reactionsCheckpoint inhibitor therapyCutaneous adverse eventsOngoing cancer treatmentPD-1 inhibitorsCTLA-4 inhibitorsImmune checkpoint inhibitorsCutaneous adverse reactionsPD-L1 inhibitorsDevelopment of immunotherapySuch adverse reactionsImmunomodulatory therapyTreatment interruptionAssociated morbidityPatient comorbiditiesAdverse eventsCutaneous toxicityInhibitor therapyImmune statusHematologic malignanciesEarly recognitionCancer treatmentManagement guidelinesPleural Effusions After Congenital Cardiac Surgery Requiring Readmission: A Systematic Review and Meta-analysis
Hughes A, Carter K, Cyrus J, Karam O. Pleural Effusions After Congenital Cardiac Surgery Requiring Readmission: A Systematic Review and Meta-analysis. Pediatric Cardiology 2020, 41: 1145-1152. PMID: 32424719, DOI: 10.1007/s00246-020-02365-4.Peer-Reviewed Original ResearchConceptsCongenital heart diseaseSingle-ventricle palliationPleural effusionRisk factorsPost-pericardiotomy syndromeImproved risk stratificationSingle ventricle physiologySubpopulation of patientsAdditional invasive proceduresRandom-effects modelFull-text articlesBiventricular physiologyHospital dischargeSurgical patientsCardiopulmonary bypassRisk stratificationPatient populationEarly recognitionHeart diseaseOverall prevalenceSurgical techniqueFallot patientsInvasive proceduresReadmissionPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply